(Q61713430)

English

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

ChEBI release 2020-05-28

0 references

1 reference

based on heuristic

inferred from title

Clostridium difficile

object named as

Clostridium difficile

1 reference

based on heuristic

inferred from title

Oliver A Cornely

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Derrick W Crook

2

object named as

Derrick W Crook

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Roberto Esposito

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

André Poirier

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michael S Somero

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Karl Weiss

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Pamela Sears

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sherwood Gorbach

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

OPT-80-004 Clinical Study Group

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

8 February 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lancet Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

281-289

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial-associated risk factors for Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease associated with Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clostridium difficile infection in Europe: a hospital-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing epidemiology of Clostridium difficile infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fidaxomicin versus vancomycin for Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of strain typing results for Clostridium difficile isolates from North America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(11)70374-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61713430&oldid=1983488952"